Amiodarone and miltefosine act synergistically against Leishmania mexicana and can induce parasitological cure in a murine model of cutaneous leishmaniasis.
about
In vitro and in vivo efficacy of ether lipid edelfosine against Leishmania spp. and SbV-resistant parasitesDrug discovery algorithm for cutaneous leishmaniasis.A current perspective on leishmaniasisPotent In Vitro Antiproliferative Synergism of Combinations of Ergosterol Biosynthesis Inhibitors against Leishmania amazonensis.Drug resistance in leishmaniasis: current drug-delivery systems and future perspectives.Antiproliferative, Ultrastructural, and Physiological Effects of Amiodarone on Promastigote and Amastigote Forms of Leishmania amazonensis.Repurposing as a strategy for the discovery of new anti-leishmanials: the-state-of-the-art.Nuclear DNA replication and repair in parasites of the genus Leishmania: Exploiting differences to develop innovative therapeutic approaches.In vitro anti-Trypanosoma cruzi activity of dronedarone, a novel amiodarone derivative with an improved safety profile.Dronedarone, an amiodarone analog with improved anti-Leishmania mexicana efficacy.Comparative analyses of the β-tubulin gene and molecular modeling reveal molecular insight into the colchicine resistance in kinetoplastids organisms.Quinolinic alkaloids from Galipea longiflora Krause suppress production of proinflammatory cytokines in vitro and control inflammation in vivo upon Leishmania infection in mice.In vivo antileishmanial efficacy of miltefosine against Leishmania (Leishmania) amazonensis.Mechanism of Action of Miltefosine on Leishmania donovani Involves the Impairment of Acidocalcisome Function and the Activation of the Sphingosine-Dependent Plasma Membrane Ca2+ Channel.Potential utility of hyperbaric oxygen therapy and propolis in enhancing the leishmanicidal activity of glucantime.Evaluation of the effect of miltefosine on Trichomonas vaginalis.Activity of the antiarrhythmic drug amiodarone against () : an in vitro and in vivo approach
P2860
Q28482212-DDE08D67-988A-4748-84A3-A64C7CFA55C4Q30414859-51FBC5C9-B80F-40B9-B8B9-DBD46025F34EQ33929832-C550F878-C699-45F3-8243-9E0CB767C7C8Q36075944-19F70FA1-EDE5-4C2C-9A45-BBFCB98A9B92Q38154347-1C38965C-2654-450E-8491-6379690C4E9DQ38805947-8C1AAA67-A103-407F-BA4F-91FD33CFB7F3Q38939544-4C760BE8-48F3-46E5-B742-7D1CC5F01CB0Q39037726-8CDAA528-DA13-4634-B858-D05ADB7E4842Q39628520-64F98A56-25A0-4388-9C60-345267B7BD63Q39683991-506791FA-1F99-4005-8737-3294677938E1Q42971520-68822CB0-6C0A-4A8C-AEC2-5A1C4943D57FQ43754010-3C94CFF7-389D-4380-AD83-4EB2E50846A1Q46867851-AE1177C1-C09A-4F88-95F6-DC307A1E154DQ50072881-159983FC-0520-4CAF-9447-3290EC9BA94CQ50520445-648FF605-C24E-43DD-BC63-B8DAAD059EFAQ54406204-37248D0A-F704-4F8A-A370-790FD3CE8309Q58560098-7BCB6C25-3833-4B88-8E61-FC0B41FD1E6B
P2860
Amiodarone and miltefosine act synergistically against Leishmania mexicana and can induce parasitological cure in a murine model of cutaneous leishmaniasis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 October 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Amiodarone and miltefosine act ...... el of cutaneous leishmaniasis.
@en
Amiodarone and miltefosine act ...... el of cutaneous leishmaniasis.
@nl
type
label
Amiodarone and miltefosine act ...... el of cutaneous leishmaniasis.
@en
Amiodarone and miltefosine act ...... el of cutaneous leishmaniasis.
@nl
prefLabel
Amiodarone and miltefosine act ...... el of cutaneous leishmaniasis.
@en
Amiodarone and miltefosine act ...... el of cutaneous leishmaniasis.
@nl
P2093
P2860
P356
P1476
Amiodarone and miltefosine act ...... el of cutaneous leishmaniasis.
@en
P2093
Alexis Mendoza-León
Gilberto Payares
Gustavo Benaim
Juan Carlos Martinez
Marisel De Lucca
Xenón Serrano-Martín
P2860
P304
P356
10.1128/AAC.00505-09
P407
P577
2009-10-05T00:00:00Z